Home > Press > Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system
Dolomite’s novel Mitos Dropix system |
Abstract:
Microfluidic products expert Dolomite has launched Mitos Dropix, an ingenious droplet-on-demand system capable of easily generating extremely miniaturised droplet compartments with exceptional control over volume, environment and isolation of contents. Meeting the increasing demand for screening massive numbers of biological reactions, increased speed of screening and reduced reagent consumption, Mitos Dropix technology now introduces liquid sampling and processing over a very wide 10 nL - 50 μL volume range utilizing droplet technology.
Mitos Dropix will be invaluable to application areas such as droplet library creation, cell encapsulation, diagnosis screening, synthetic chemistry and drug bioassays, as well as being applicable to high-throughput screening formats.
Mitos Dropix is a compact, off-chip droplet generator that features a patented droplet "picking" technology. It was developed by Dolomite under exclusive sub-licence with Drop-Tech Ltd. having won Dolomite's 2012 Productizing Science® competition. Drop- Tech was formed from an academic collaboration between Cambridge University and Imperial College London and is the exclusive licensee of their patented droplet generation technology used in Mitos Dropix (Patent Pending: PCT/GB2013/051668).
There are 24 wells in total, allowing users to combine multiple reagents to create complex assays, resulting in up to 300 combinations. 8 sample strips can also be inserted into the Dropix Sample Strip Holder thereby creating a 192 well plate configuration which facilitates preparation and allows integration with existing standard fluid handling systems. Mitos Dropix is capable of consistently generating and storing up to 1000 droplets, with accurate user-defined control of droplet size (ranging in volume from a few 10's of nanoliters to a microliter) and frequency (up to 5Hz of one sample) achieved via Dropix PC software.
The following application note demonstrates the capabilities of the Mitos Dropix system for droplet-on-demand sequencing and droplet library generation: www.dolomite- microfluidics.com/images/stories/PDFs/dropix_application_note.pdf
For further information on Dolomite's Mitos Dropix system as well as a complete portfolio of microfluidic products including chips, connectors, valves and custom devices please see www.dolomite-microfluidics.com
####
About The Dolomite Centre Ltd
Established in 2005 as the world’s first Microfluidic Application Centre, Dolomite focused on working with customers to turn their concepts for microfluidic applications into reality. Today, Dolomite is the world leader in solving microfluidic problems. With offices in the UK and US and distributors throughout the rest of the world, its clients range from universities developing leading-edge analytical equipment, to manufacturers of chemical, life sciences and clinical diagnostics systems.
Dolomite is pioneering the use of microfluidic devices for small-scale fluid control and analysis, enabling manufacturers to develop more compact, cost-effective and powerful instruments. By combining specialist glass, quartz and ceramic technologies with knowledge of high performance microfluidics, Dolomite is able to provide solutions for a broad range of application areas including environmental monitoring, clinical diagnostics, food and beverage, nuclear, agriculture, petrochemical, cosmetics, pharmaceuticals and chemicals. Furthermore Dolomite's in-house micro-fabrication facilities that include clean rooms and precision glass processing facilities allow to prototype and test all solutions rapidly which ensures a faster development cycle and reduces the time to market.
For more information, please click here
Contacts:
The Dolomite Centre Ltd
Unit 1, Anglian Business Park
Orchard Road
Royston, Hertfordshire, SG8 5TW, UK
T: +44 (0)1763 242491
F: +44 (0)1763 246125
Copyright © The Dolomite Centre Ltd
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Tools
Ferroelectrically modulate the Fermi level of graphene oxide to enhance SERS response November 3rd, 2023
The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||